Skip to main content
OpenTrials
Completed

NCT Number: NCT04135274

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • <28 days diagnosed with with neural Tüpe Defects To be operated

Exclusion criteria

  • >28 days

Treatment and study plan

Neutrophil to lymphocyte ratio

Diagnostic Test

Neutrophil to lymphocyte ratio

Primary outcomes

  1. Neutrophil to lymphocyte ratio is prognostic faktör for Sepsis

    Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Tepecik Training and Research Hospital

Other

Registry information

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
Oct 22, 2019
Registry last updated
Oct 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.